GRP94
1 (gp96, ERp99, endoplasmin), the endoplasmic reticulum paralog of cytosolic Hsp90, serves a molecular chaperone function in the endoplasmic reticulum and is known to interact with nascent immunoglobins, major histocompatibility complex class II molecules, HSV-1 glycoproteins, thyroglobulin, collagen, and p185
ErbB2 (1) (2) (3) (4) (5) (6) (7) . In addition to interactions with polypeptide folding substrates, it is now established that GRP94 binds peptides, a subset of which are suitable for assembly on nascent major histocompatibility complex class I molecules (8 -14) . The peptide binding activity of GRP94 is integral to its now established ability to elicit CD8 ϩ T cell immune responses (13, (15) (16) (17) (18) (19) (20) . Peptide binding activity is not, however, alone sufficient to impart immunogenic activity to a protein and thus GRP94 is among a limited subset of molecular chaperones that can function in the essential immunological process of cross-presentation (13, 18, 21, 22) . To date, the mechanisms responsible for regulating the interactions of GRP94 with both polypeptide and peptide substrates remain to be determined.
Given the high sequence identity between GRP94 and Hsp90 it is reasonable to assume that the two paralogs are regulated by a similar, if not identical, mechanism. Hsp90 function in protein folding is known to require the activity of a series of co-chaperones and accessory molecules, including Hsp70, p48
Hip , p60 Hop , p23, and FKBP52 (23) (24) (25) (26) (27) (28) (29) (30) . These co-chaperones and accessory molecules participate in both concerted and sequential interactions with Hsp90 and thereby serve to regulate its chaperone activity (31) (32) (33) (34) . In addition to the contribution of co-chaperone proteins to the regulation of Hsp90 function, recent crystallographic studies have identified an unconventional ATP/ADP binding pocket in the N-terminal domain of yeast and human Hsp90, suggesting that Hsp90 activity is regulated through cyclic ATP binding and hydrolysis, as has been established for the Hsp70 family of chaperones (35) (36) (37) (38) (39) (40) . Indeed, experimental evidence for a role of ATP in the regulation of Hsp90 function is long standing (34, 39, 40 -47) . Beginning with earlier, sequence-based analyses, it was reported that Hsp90 contained motifs bearing significant similarities to the Walker "A" and "B" sequences associated with ATP binding (41, 48) . Although these sequences are substantially different from the consensus sequences found among serine and tyrosine kinases, they are homologous to the ATP binding sequence seen in the Hsp70 family of proteins (41) . Consistent with sequence predictions, ATP binding, autophosphorylation activity, and ATPase activity have all been demonstrated for Hsp90, although these findings are not without controversy (39, 41, 44, (47) (48) (49) .
In part because of the very low affinity of Hsp90 for ATP, a role for ATP in the regulation of Hsp90 function remained under question until crystallographic resolution of the N-terminal domain of yeast and human Hsp90 in association with bound adenosine nucleotides (39, 40) . Aided by atomic scale structural insights, amino acid residues critical for ATP binding and hydrolysis were subsequently identified (39, 40, 46) . Thus, in the human Hsp90, aspartate 93 (Asp-128 for GRP94; Asp-79 for yeast) provides a direct hydrogen bond interaction with the N-6 of the purine moiety of the adenosine ring and is essential for ATP binding (39, 40) . Glutamate 47 (Glu-82 for GRP94; Glu-33 in yeast) was postulated to play an important catalytic role in ATP hydrolysis, based both on its location relative to bound nucleotide and through comparison with the ATP-binding domain of Escherichia coli DNA gyrase B (39, 40) . In subsequent mutagenesis studies of yeast Hsp90, it was observed that a Asp-79 mutant was deficient in ATP binding and that Glu-47 mutants were deficient in ATP hydrolysis activity (40, 46) . As further evidence for an essential function of these residues in Hsp90 activity, yeast containing either mutant form of the Hsp90 gene were inviable (40, 46) .
As previously noted, Hsp90 and GRP94 share high sequence identity and presumably identical adenosine nucleotidedependent modes of regulation. Past investigations suggest, however, that Hsp90 and GRP94 may differ in their nucleotide binding properties. For example, studies on the identification and characterization of adenosine A 2 receptors, performed with the adenosine A 2 agonist 5Ј-(N-ethylcarboxamido)adenosine (NECA), identified GRP94, but not Hsp90, as an abundant NECA-binding protein (50, 51) . In these studies, it was reported that GRP94 displayed submicromolar affinity for NECA and did not bind N-6-or C-8-substituted adenosine derivatives (52, 53) . These observations are intriguing in that they directly corroborate crystallographic data identifying critical binding interactions for the N 6 -adenine in the adenosine nucleotide binding of Hsp90 as well as the hindered conformation of the C-8 adenine in the Hsp90-bound state (39, 40) .
Although ATP binding and hydrolysis are generally accepted as biological properties of Hsp90, it is not known whether ATP/ADP serve an identical function(s) in the regulation of GRP94 activity. To date, neither ATP nor ADP have been demonstrated to regulate the (poly)peptide binding activity of GRP94, nor has a functional correlate to the low level ATPase and autophosphorylation activities of GRP94 been identified (11, 54, 55) . To investigate adenosine nucleotide interactions with GRP94, we utilized NECA in analyses of the kinetics, stoichiometry, specificity, and enzymatic consequences of nucleotide binding to GRP94. We report that GRP94 and Hsp90 can be readily distinguished by virtue of their capacity to bind NECA, although both proteins bind the N-terminal nucleotide binding pocket antagonists geldanamycin and radicicol and both geldanamycin and radicicol compete NECA binding to GRP94. GRP94 bound NECA at a stoichiometry of 0.5 mol of NECA:mol of GRP94. Given the apparent half-site stoichiometry of NECA binding to GRP94, a model of allosteric regulation (negative cooperativity) for NECA/GRP94 interactions is proposed.
MATERIALS AND METHODS
Purification of GRP94, BiP, and Hsp90 -GRP94 was purified from porcine pancreas rough microsomes as described previously (56) with the following modifications. Rough microsomes were washed after the initial isolation by 10-fold dilution in 0.25 M sucrose, 20 mM KOAc, 25 mM K-Hepes, pH 7.2, 5 mM Mg(OAc) 2 and subsequent re-isolation by centrifugation (30 min, 40,000 rpm, 4°C, Ti50.2 rotor). To release the lumenal contents from the washed rough microsomes, 5 mM CHAPS was added to the microsome suspension (50 A 280 units/ml) and the lumenal contents were subsequently separated from the membrane fraction by centrifugation for 2 h at 45,000 rpm (4°C, Ti50.2 rotor).
BiP was purified by the following procedure. A lumenal protein fraction obtained from porcine pancreas rough microsomes was cycled overnight through a 1-ml ADP-agarose and a 1-ml ATP-agarose (Sigma) column coupled in series. The columns were then washed with 2 ϫ 5 ml of a buffer containing 350 mM NaCl, 25 mM Tris, pH 7.8, 5 mM Mg 2ϩ and the BiP was eluted from the nucleotide affinity columns with 3 ϫ 5 ml of the identical buffer supplemented with 10 mM ATP and ADP. The BiP containing fractions were identified by SDS-PAGE, and dialyzed against 2 ϫ 4 liters of buffer A (110 mM KOAc, 20 mM NaCl, 25 mM K-Hepes, pH 7.2, 2 mM Mg(OAc) 2 , 0.1 mM CaCl 2 ). The protein sample was then applied to a Superdex 26/60 column (Amersham Pharmacia Biotech) equilibrated in buffer A, and the BiP containing fractions, again identified by SDS-PAGE, were pooled and concentrated by centrifugal ultrafiltration (Centricon-30; Amicon, Beverly, MA).
Hsp90 was purified from rat liver cytosol as follows. Cytosol was adjusted to 30% ammonium sulfate and stirred for 60 min on ice. The solution was centrifuged at 20,000 ϫ g in a Sorvall SS34 rotor for 15 min and the supernatant collected and filtered through a 0.22-m filter. The filtered supernatant was supplemented with protease inhibitors (1 g/ml pepstatin, 1 g/ml leupeptin, 20 g/ml soybean trypsin inhibitor, and 0.5 mM phenylmethylsulfonyl fluoride) and loaded onto a phenylSuperose HR10/10 column (Amersham Pharmacia Biotech). After washing, the bound proteins were eluted with a gradient of 30 -0% saturated ammonium sulfate in 10 mM Tris/HCl, pH 7.5, 1 mM EGTA, 0.5 mM dithiothreitol and the Hsp90 containing fractions were identified by SDS-PAGE. The Hsp90 containing fractions were then pooled and dialyzed 2 ϫ 3 h against 2 liters of low salt buffer (10 mM NaCl, 25 mM Tris, pH 7.8). The dialyzed sample was then filtered through a 0.22-m filter, and injected onto a MonoQ HR 10/10 column (Amersham Pharmacia Biotech) equilibrated in low salt buffer. The column was eluted with a gradient of 10 -750 mM NaCl in 25 mM Tris, pH 7.8. The Hsp90-containing fractions were identified by SDS-PAGE and pooled. Further purification was achieved by applying the Mono-Q pool to a 4-ml hydroxylapatite column (Bio-Rad HTP) equilibrated in buffer B (10 mM NaH 2 PO 4 , pH 6.8, 10 mM KCl, and 90 mM NaCl). The hydroxylapatite column was eluted with a 10 mM NaH 2 PO 4 to 250 mM NaH 2 PO 4 , gradient and the Hsp90 fractions were identified by SDS-PAGE. The Hsp90 pool, in 225 mM NaH 2 PO 4 , 10 mM KCl, and 90 mM NaCl, was concentrated by centrifugal ultrafiltration (Centricon-30; Amicon, Beverly, MA) and stored at Ϫ80°C.
[ 32 P]ATP was separated by vacuum filtration. Filters were washed with 3 ϫ 2 ml of ice-cold buffer B, placed in 5 ml of scintillation fluid, vortexed, and counted.
Isothermal Titration Calorimetry-Isothermal calorimetry experiments were performed at 25°C using a MSC isothermal titration calorimeter (MicroCal Inc., Northampton, MA). To determine the NECA binding parameters, two 5-l injections were followed by 23 10-l injections from a 152 M NECA stock. The reaction chamber (1.3 ml) contained 5 M GRP94. Necessary corrections were made by subtracting the heats of dilution resulting from buffer addition to protein solution and ligand solution into buffer. The corrected data were then fit by the Origin software (57) to obtain the binding parameters. The radicicol binding parameters were obtained in a similar injection protocol with 5 M GRP94 and 115 M radicicol.
Phosphorylation Assays-To assay for GRP94 autophosphorylation, 1 M GRP94 was incubated with [␥-32 P]ATP (6000 cpm/pmol)(Amersham Pharmacia Biotech), diluted with cold ATP to yield a final concentration of 0.15 mM ATP, in a buffer containing 10 mM Mg(OAc) 2 and 50 mM K-Hepes, pH 7.4. For the casein kinase assay, 1 unit of casein kinase II was incubated as described above, with the addition of 4 M casein. Competitors were added to the appropriate samples to yield final concentrations of 180 M NECA in 3.6% Me 2 SO, 180 M radicicol in 3.6% Me 2 SO, 5 g/ml heparin, 5 mM GTP, or 3.6% Me 2 SO. The 25-l reaction mixtures were incubated at 37°C for 1 h and quenched by addition of 10% trichloroacetic acid. Samples were analyzed by 10% SDS-PAGE gels and the phosphorylated species were quantitated using a Fuji MacBas1000 PhosphorImaging system (Fuji Medical Systems, Stamford, CT).
ATPase Assay-100-l reactions consisting of 0.5 or 1 M GRP94 dimer, various concentrations of MgATP, pH 7.0, and 50 mM K-Hepes, pH 7.4, were incubated for 2 h at 37°C. Where indicated, NECA was present at a concentration of 0.5 mM. At the completion of the incubation, samples were centrifuged through a Centricon-30 centrifugal ultrafiltration device (Amicon) at 5,000 rpm, 4°C to separate protein from nucleotide. Filtrates were then supplemented with a buffer/nucleotide solution to yield a final concentration of 50 mM (NH 4 ) 2 HPO 4 , pH 7.0, and 4 M AMP, pH 7.0. 100-l sample aliquots were then fractionated on a Partisil SAX column (Alltech, Deerfield, IL), using a Series 1050 Hewlett-Packard high performance liquid chromatography system. Elution of nucleotides was performed by step gradient elution using a mobile phase of 150 mM (NH 4 ) 2 HPO 4 , pH 5.2. Typically elution was conducted at 1.2 ml/min for the first 10 min, followed by 300 mM (NH 4 ) 2 HPO 4 , pH 5.2, at a flow rate of 2 ml/min for the remainder of the elution. In this protocol, ADP and ATP were well resolved, with ADP eluting at 7 min and ATP at 12 min. To allow baseline resolution of samples containing added NECA, a modified gradient elution protocol, consisting of a 16-min elution in 150 mM (NH 4 ) 2 HPO 4 , pH 5.2, at 0.25 ml/min, 5-min elution at 1.2 ml/min, and at 21 min the buffer was switched to 300 mM (NH 4 ) 2 HPO 4 , pH 5.2, with a flow rate of 2 ml/min for the remainder of the elution. Peak height values were used in calculations of percent hydrolysis and ADP formation. Spontaneous hydrolysis was determined for each ATP concentration in paired incubations lacking GRP94. Added AMP was used as an internal reference standard to control for equivalent sample loading.
Tryptophan Fluorescence-Tryptophan fluorescence measurements were conducted in a Fluoromax spectrofluorometer (Spex Industries, Inc., Edison, NJ) with the slit widths set to 1 nm for both excitation and emission. Samples were excited at a wavelength of 295 nm and the emission spectra were recorded from 300 to 400 nm. All spectra were corrected by subtraction of buffer or buffer plus ligand samples. GRP94 (50 g/ml) was incubated in buffer A supplemented with 10 mM Mg(OAc) 2 and the following concentrations of ligands for 1 h at 37°C (50 M NECA, 50 M geldanamycin, 2.5 mM ATP, or 2.5 mM ADP). Samples were then cooled to room temperature, transferred to a quartz cuvette, and the spectra collected. In control experiments, free tryptophan fluorescence was not significantly influenced by the presence of any of the assayed ligands.
RESULTS

Hsp90 Proteins Differ in Adenosine-based Ligand Binding
Properties-Previously, radioligand binding studies with NECA, an adenosine A 2 receptor agonist, yielded the identification of GRP94 as a NECA-binding protein (50, 51) . Given the high structural similarities between Hsp90 and GRP94, and the observation that GRP94 alone was purified as a NECAbinding protein from the soluble fraction of tissue homogenates, these results were unexpected, as they suggested that the Hsp90 and GRP94 differ in adenosine ligand binding characteristics. To directly determine whether Hsp90 and GRP94 displayed distinct adenosine-ligand binding properties, the relative NECA and ATP binding activities of GRP94, Hsp90, and BiP, the endoplasmic reticulum Hsp70 paralog, were compared ( Fig. 1) . In these assays, GRP94, Hsp90, or BiP were incubated on ice for 60 min in the presence of 20 nM [ 3 H]NECA and the bound versus free NECA resolved by vacuum filtration. As is evident in Fig. 1 When ATP binding was assayed, BiP displayed the expected ATP binding activity. Neither Hsp90 nor GRP94 were observed to bind ATP by this assay procedure. As will be later discussed, our inability to detect ATP binding to Hsp90 is likely a consequence of the low affinity of Hsp90 for ATP (39, 44) . In summary, these data indicate that GRP94 and Hsp90 differ in their ability to bind the adenosine-based ligand NECA, and suggest that the ligand specificity of the adenosine nucleotide binding pocket of GRP94 differs from that of Hsp90.
Kinetic Analysis of NECA Binding to GRP94 -A kinetic analysis of [
3 H]NECA binding to GRP94 is depicted in Fig. 2 , panels A and B. As is evident from the data transformations depicted in Fig. 2 , panels A and B, [ 3 H]NECA binding to GRP94 was saturable and displayed an equilibrium dissociation constant of 200 nM. NECA was observed to bind to GRP94 at a stoichiometry of 0.5 mol of [ 3 H]NECA/mol of GRP94 monomer. These values are similar to those observed previously with placental GPR94 (adenotin) (51) .
Structurally, GRP94 exists as a dimer of identical subunits (56, 58, 59) . Given that the two subunits are identical, a 50% ligand occupancy at binding saturation was unexpected. The dissociation rate of NECA from GRP94 is rapid, however (53), 2 and so it was considered that the observed 50% occupancy level could reflect an artifact of the method used to separate bound versus free [ 3 H]NECA. To evaluate the accuracy of the half-site occupancy value, the NECA binding stoichiometry was further evaluated by isothermal titration calorimetry, a method that does not require the physical separation of bound and free ligand. In these experiments, illustrated in Fig. 2, panel C , the binding stoichiometries of GRP94 for NECA and radicicol were determined. Radicicol is an antibiotic inhibitor of Hsp90 that binds to the N-terminal nucleotide binding pocket of Hsp90 with high affinity (19 nM) and the expected binding stoichiometry of 2 mol of radicicol/mol of Hsp90 dimer (60) . Analysis of NECA binding to GRP94 by isothermal titration calorimetry yielded a binding stoichiometry of 1.1 mol of NECA/mol of GRP94 dimer (Fig. 2, panel C) . Radicicol, in contrast, bound at a stoichiometry of 2 mol of radicicol/mol of GRP94 dimer, consistent with previous results (60) (Fig. 2, panel C) . These data indicate that while radicicol can achieve full occupancy of the two nucleotide-binding sites present in the native GRP94 dimer, other ligands, such as NECA, either bind to a single unique site on GRP94, or upon binding to one of the nucleotidebinding sites, elicit a conformational change in the paired site that prevents further ligand binding. site occupancy of the N-terminal adenosine nucleotide binding pockets, the structural specificity of NECA binding was examined. Initially, [ 3 H]NECA competition assays were performed with geldanamycin and radicicol, both of which are known to bind with high affinities to the nucleotide binding pocket of Hsp90 (60, 61) . The data depicted in Fig. 3A indicate that both geldanamycin and radicicol compete with [ 3 H]NECA for binding to GRP94 and do so with high relative affinities and in the rank order (radicicol Ͼ geldanamycin) predicted from previous studies (60, 62) .
Specificity of Ligand Binding to the Nucleotide Binding
In a past study, we reported data indicating that GRP94 was not an ATP-binding protein (10) . However, should GRP94 display an affinity for ATP similar to that reported for the Nterminal domain of Hsp90 (K d ϭ 132 M) (39), it would be very unlikely that ATP binding would be detected by the radioligand binding techniques used in the previous study. Given the relatively high affinity of GRP94 for NECA, however, ligand binding interactions at the nucleotide-binding domain could be addressed by competitive displacement assays. Thus, the ability of ATP, ADP, or AMP to compete with NECA binding to GRP94 was examined (Fig. 3, panel B) . In these experiments, GRP94 was incubated with 20 nM [ 3 H]NECA for binding to GRP94. Three points are evident from these experiments. One, because NECA binding to GRP94 can be effectively inhibited by geldanamycin, radicicol, and adenosine nucleotides, NECA likely binds to the N-terminal adenosine nucleotidebinding domain of GRP94. Two, the relative affinities of GRP94 for adenosine nucleotides was quite low. Thus, a 50% inhibition of [ 3 H]NECA binding required approximately a 1000-fold molar excess of ATP. Three, the relatively high binding affinity of GRP94 for NECA, when viewed with respect to the established molecular interactions of the adenine and ribose moieties of adenosine in the adenosine nucleotide binding pocket of Hsp90, suggest that a principal selection for ligands is made on the basis of the adenosine moiety. For this reason, the interaction of other adenosine-bearing ligands with the N-terminal nucleotide binding pocket was examined (Fig. 3, panel C) . These data indicated that cAMP and free adenosine also bound to the N-terminal adenosine nucleotide binding pocket of GRP94, with the relative displacement activity approximating that observed for ADP (Fig. 3, panel B) .
Because our data indicated that GRP94 bound adenosine, adenosine derivatives, and adenosine nucleotides with an unusually broad specificity, additional studies were performed to confirm the nucleoside specificity of these binding phenomena. In the experiment detailed in Fig. 4, the [ 3 H]NECA competitive displacement assay was used to address the nucleoside base specificity of potential ligands. Although GRP94 could bind both ATP and deoxy-ATP, little to no binding of GTP, CTP, or UTP was observed. The nucleotide binding pocket of GRP94 thus appears to be strict in its selection of adenosine-bearing ligands.
In comparing the relative affinities of GRP94 for ATP and ADP, as displayed in NECA competition assays, clear differences between the ATP/ADP binding properties of GRP94 and those previously reported for Hsp90 were noted. Regarding GRP94, ATP was found to compete NECA binding with an 8-fold higher efficacy than ADP. In contrast, the N-terminal domain of Hsp90 binds ADP with a 4-fold higher affinity than that observed for ATP (39) . We hypothesized that this difference was due to a lack of Mg 2ϩ ions in our assay buffer, as Mg 2ϩ has been demonstrated to be essential for ATP/ADP binding to recombinant forms of the Hsp90 N-terminal nucleotide-binding domain (39, 40) . This hypothesis was examined in experiments where the relative affinity of GRP94 for NECA, adenosine, ATP, ADP, and AMP were compared in the presence and absence of excess Mg 2ϩ (Fig. 5) . In these experiments, it was observed that although excess Mg 2ϩ was without effect on the binding of NECA or adenosine to GRP94, Mg 2ϩ markedly stimulated the binding of ATP, ADP, and AMP. These data are consistent with recent crystal structure data identifying Mg 2ϩ interactions with the ␣ and ␤ phosphates as being requisite for ATP/ADP binding to the N-terminal domain of Hsp90 (39) . However, unlike the N-terminal domain of Hsp90, MgATP and MgADP bind to GRP94 with similar relative affinities. It should also be noted that the presence of excess Mg 2ϩ was without effect on the relative binding affinities of cAMP and geldanamycin for GRP94 (data not shown).
Nucleotide Requirement for Autophosphorylation and ATP Hydrolysis-The identification of NECA as a ligand for the N-terminal nucleotide-binding domain of GRP94 allowed the re-evaluation of previous conclusions indicating that autophosphorylation and ATP hydrolysis did not contribute to GRP94 function, as displayed in peptide binding activity (10) . The importance of such experiments was made evident in recent studies indicating that ATP hydrolysis is an integral element of Hsp90 function (40, 46) . To determine whether ATP binding to the nucleotide binding pocket is directly responsible for the observed GRP94 autophosphorylation activity, we utilized NECA and radicicol as inhibitors of ATP binding to GRP94. Data regarding autophosphorylation activities are shown in Fig. 6A . In this experiment, the autophosphorylation activity of GRP94 was assayed in the presence of NECA, radicicol, heparin, and GTP. Heparin and GTP were included on the basis of previous studies indicating a casein kinase II-like contaminant in purified preparations of GRP94 (10, 63, 64, 67) . By similar logic, the relative effects of these compounds on GRP94 kinase activity were compared in parallel with purified casein kinase II, with casein kinase II activity measured with purified casein. As is evident from the data presented in Fig. 6A , neither NECA nor radicicol, both of which bind to the N-terminal nucleotidebinding domain of GRP94, substantially inhibit GRP94 or casein kinase II phosphorylation activity below the solvent background. Because of the relatively high hydrophobicity of NECA and radicicol, incubations containing these compounds contained significant concentrations of the ligand solvent, dimethyl sulfoxide, which itself significantly reduced both the GRP94-derived and casein kinase II activities. Consistent with previous reports, heparin and GTP markedly attenuated GRP94-derived and casein kinase II activity (10) . In summary, blocking nucleotide access to the N-terminal adenosine nucleotide binding pocket did not significantly inhibit GRP94 autophosphorylation activity.
Our data showing that Hsp90 and GRP94 differ in ligand binding to the N-terminal nucleotide-binding domain suggests a potential explanation for previous conclusions that the ATPase activity of GRP94 does not contribute to the regulation of GRP94 function (10) . In earlier experiments, the ATPase activity of GRP94 was examined at ATP concentrations that, assuming the K d for ATP binding to GRP94 approximates that seen for Hsp90 (132 M) (39), were significantly below saturation and thus may have led to erroneous conclusions. To reexamine these conclusions, the ATPase activity of GRP94 was assayed at substantially higher ATP concentrations (Fig. 6B) . Two points are immediately evident from the data in Fig. 6B . First, the ATPase activity does not display saturation; no evidence for a V max could be obtained and so traditional criteria for enzymatic function (i.e. K m /Kcat/V max ) could not be applied. Second, the absolute magnitude of the ATPase activity exceeded the spontaneous rate of ATP hydrolysis by only a small factor. More significantly, in the presence of NECA concentrations sufficient to inhibit ATP binding, no significant decrease in ATPase activity was observed (Fig. 6C ). Furthermore, the low level of ATP hydrolysis did not vary with GRP94 concentration (Fig. 6C) . Thus, the observed ATPase activity is likely generated by a low level contaminant, and possibly the same contaminant seen in the autophosphorylation assays.
Conformational Consequences of Adenosine Nucleotide Binding to GRP94 -To gain insights into the structural consequences of ATP, ADP, NECA, and geldanamycin binding to GRP94, tryptophan fluorescence studies were performed. In these studies, the tryptophan emission spectra of GRP94, complexed with the indicated ligands, was examined as a measure of tertiary conformational state (65) . As shown in Fig. 7 , high concentrations of ATP or ADP elicited near identical changes in the GRP94 tryptophan fluorescence spectra. Significantly, in the presence of ATP or ADP, the tryptophan fluorescence was decreased. Interestingly, a similar change in GRP94 tryptophan fluorescence was observed in the presence of geldanamycin. These data suggest that ATP and ADP elicit a conformational change in GRP94 similar to that occurring in the presence of the inhibitory ligand geldanamycin. In contrast, the addition of NECA increased the tryptophan fluorescence, indi- FIG. 7 . Ligand induced conformational changes of GRP94. GRP94 (50 g/ml) was incubated in buffer A supplemented with 10 mM Mg(OAc) 2 and the following concentrations of ligands for 1 h at 37°C (50 M NECA, 50 M geldanamycin, 2.5 mM ATP, or 2.5 mM ADP). Samples were excited at a wavelength of 295 nm and the tryptophan emission spectra were recorded from 300 to 400 nm. All spectra were corrected by subtraction of spectra obtained in buffer alone and buffer ϩ ligand samples. cating that ligands can elicit different conformational states in GRP94. As demonstrated in the accompanying manuscript (69) , such changes in GRP94 conformation can have dramatic effects on GRP94 chaperone function.
DISCUSSION
In this article, we report that the Hsp90 paralogs GRP94 and Hsp90 display distinct structural and functional interactions with adenosine nucleotides. Unlike Hsp90, GRP94 displays specific, high affinity binding interactions with the substituted adenosine derivative NECA. In analyzing such interactions, we propose that NECA binding to GRP94 is under allosteric regulation and, with a maximal 50% ligand occupancy, displays negative cooperativity. Analysis of the nucleotide binding properties of GRP94 indicate that ligand selection is based primarily on the adenosine moiety, and thus significant binding interactions between GRP94 and ATP, dATP, ADP, AMP, cAMP, or free adenosine were observed.
NECA, an adenosine receptor agonist, was first identified as a ligand for GRP94 in studies of the distribution and pharmacological profile of NECA-binding sites (50, 51) . It is important to note that in these studies, NECA binding activity was observed in cytosol fractions derived from tissue homogenates, yet the vast majority of the cytosolic NECA binding activity could be attributed to GRP94, rather than Hsp90 (51) . Given the structural similarities between the adenosine nucleotidebinding domains of the two proteins, this is surprising. In detail, N 6 -substituted adenosine analogs do not bind to GRP94 (51) (data not shown), as would be predicted given that the N-6 of the adenine purine is the sole direct hydrogen bond between the nucleotide and the nucleotide binding pocket (39, 40) . Furthermore, those amino acid side chains that participate in water-mediated hydrogen bonds with the N-7 of the purine ring (N-51 in human Hsp90 ϭ N-86 in GRP94), the N-1 of the purine ring (G-97 in human Hsp90 ϭ G130 of GRP94), and the N-6 of the purine ring (L-48 in human Hsp90 ϭ L-83 in GRP94) are conserved between Hsp90 and GRP94. Thus, although the relevant structural components of the adenosine nucleotide binding pocket are conserved between the two proteins, the ligand specificities of the two binding sites differ. It would appear, then, that the specificity of ligand binding to the N-terminal adenosine nucleotide binding pocket is influenced by the domains C and perhaps N-terminal to the binding pocket, where significant sequence divergence between Hsp90 and GRP94 can be identified. That domains C-terminal to the adenosine nucleotide binding pocket may contribute to the regulation of ligand binding was also concluded from a recent study of radicicol binding to truncated forms of GRP94 (62) as well as from studies demonstrating that ATPase activity for Hsp90 could not be detected in the recombinant N-terminal nucleotide-binding domain, but was apparent in assays with the full-length native protein (40) .
The data obtained from both traditional ligand binding studies (Fig. 2 and Ref. 51) and isothermal titration calorimetry demonstrate that GRP94 binds NECA at a stoichiometry of 1 mol of NECA:mol of GRP94 dimer. In addition, competition studies indicate that NECA binding to GRP94 can be wholly competed by geldanamycin, radicicol, ATP, or ADP (Fig. 3) , indicating that NECA is binding to the conserved, N-terminal adenosine nucleotide-binding domain. Because GRP94 contains two such sites per molecule (58), it appears then that NECA binding to GRP94 displays negative cooperativity. As an allosteric mechanism, the existence of negative cooperativity indicates that the two subunits of GRP94 are in communication with one another, either via direct physical interaction or via communication through the C-terminal assembly domain. What might the physiological relevance of such regulation be?
It is possible that ligand binding to one domain alters the conformation of the partner domain and thereby enhances or diminishes its interactions with substrate (poly)peptides and/or accessory molecules. Coincidentally, the potent inhibition of Hsp90 function by geldanamycin and radicicol may thus reflect their ability to bind both subunits of the dimeric protein. These data also indicate that studies of ligand interactions in the intact protein may differ substantially from those observed in isolated domains and suggest the need for complementary analyses of such potentially different conformational states of the ligand binding pocket. At present, we cannot formally eliminate the possibility that NECA binds to a single unique site on GRP94, a site not present on HSP90, and thus that the observed binding parameters are representative of single site interactions. Arguing against this interpretation are the following observations: 1) NECA binding is efficiently competed with ATP, ADP, geldanamycin, and radicicol, all of which are known to bind to the N-terminal nucleotide binding fold. 2) The structural requirements for ligand binding to the nucleotide binding fold, as displayed in ligand structure, are recapitulated in NECA binding studies. Thus, for example, N 6 -substituted adenosine derivatives do not compete NECA binding to GRP94; 3) the structural elements of this unusual nucleotide binding fold, which are necessary for the unconventional bound ligand conformation, are not present in domains of GRP94 other than the N-terminal domain (68) .
The identification of ATP and ADP as ligands for the Hsp90s is based on crystallographic studies identifying an N-terminal, highly conserved nucleotide binding pocket (39) , complementary in vivo studies demonstrating that the amino acids that participate in ATP/ADP binding are essential for Hsp90 function in vivo (40, 46) , and lastly that the Hsp90s display ATPase activity (40, 47, 49) . That Hsp90 and GRP94 differ in NECA binding activity, despite the high homologies in the N-terminal nucleotide binding pockets of the two proteins, suggests that differences might also exist in the ability of the two proteins to catalyze ATP hydrolysis. In fact, when the GRP94 ATPase activity was investigated at ATP concentrations appropriate for such a low affinity interaction it was observed that the GRP94 ATPase activity barely exceeded the rate of spontaneous hydrolysis and did not saturate at increasing ATP concentrations. The low level of ATPase activity was not significantly inhibited by NECA, thereby suggesting that the observed activity is not generated from the N-terminal domain of GRP94. From these data, we conclude that the observed GRP94-dependent ATP hydrolysis, as displayed in the absence of any, as yet unidentified co-factors does not occur as a consequence of ATP binding to the nucleotide binding pocket.
Further confounding the assignment of ATP and ADP as the physiological ligands for GRP94 are the following observations. First, neither ATP nor ADP has been demonstrated to regulate GRP94 activity (10) . Second, that by virtue of its insensitivity to NECA and radicicol, the GRP94 autophosphorylation and ATPase activity does not reflect adenosine nucleotide binding to the N-terminal nucleotide-binding domain (Fig. 6A) . Third, and perhaps most importantly, ATP, ADP, and the inhibitor geldanamycin elicit similar conformational changes in GRP94. Interestingly, in the presence of NECA a different conformational change from that occurring in the presence of ATP, ADP, or geldanamycin was observed (Fig. 7) . Although a precise structural basis for the identified conformational changes has not been obtained, the data are consistent with ATP and ADP binding to GRP94 and stabilizing the protein in an inactive conformation, as is observed in the presence of geldanamycin.
As discussed in the model of the accompanying paper (69), we propose that there are distinct conformational differences in the two N-terminal pockets that confer the one site occupancy observed with NECA.
In evaluating our inability to identify an enzymatic basis for the ATPase activity and the conformation data suggesting that ATP/ADP would serve as inhibitory ligands, we speculate that either unidentified accessory proteins interact with GRP94 to substantively alter the kinetic and thermodynamic basis for its interaction with ATP/ADP or that an adenosine-based ligand, other than ATP/ADP, serves as the physiological ligand. It can be envisioned that such a ligand would be produced during times of cell stress, such as anoxia, nutrient deprivation, or heat shock, to activate GRP94 function. Principal to this proposal is the prediction that such a ligand would elicit a conformational change in GRP94 that would substantively alter its interaction with substrate (poly)peptides. Evidence for a ligand-mediated activation of GRP94 function is presented in the accompanying article (69) .
